![]() AltruBio AltruBio (formerly AbGenomics) is a biopharmaceutical company focused on developing antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases. | Takeda Oncology Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases. | Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |||
Founding Date | Founding Date 2006 | Founding Date 1978 | Founding Date 1993 | Founding Date 2008 | Founding Date 1993 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Redwood City, US HQ Amsterdam, NL | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Cambridge, US HQ | Locations Shenyang, CN HQ | |
Employees | Employees 296% decrease | Employees 16,5612% increase | Employees 1,6441% decrease | Employees 5,669 | Employees 5,577 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) N/A | Revenue (est.) ¥496.8b (FY, 2025) | Revenue (est.) ¥17.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) | Cost of goods N/A | Cost of goods ¥114.3b (FY, 2025) | Cost of goods ¥818m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ₹115.8b (FY, 2026) | Gross profit N/A | Gross profit ¥383.4b (FY, 2025) | Gross profit ¥17b (FY, 2025) |
Net income | Net income N/A | Net income ₹3.7b (FY, 2026) | Net income N/A | Net income ¥67b (FY, 2025) | Net income ¥9.1b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 39.7m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 15.2m |

Biocon is a company that develops and manufactures biopharmaceutical products.
View companyTakeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.
View companyKyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company
3sbio (三生制药集团) is a company that develops biopharmaceuticals.
View company